SANTA CLARA, Calif. – November 8, 2022 – Eliyan Corporation, credited for the invention of the semiconductor industry’s highest-performance and most efficient chiplet interconnect, today announced two major milestones in the commercialization of its technology for multi-die ch...

A recent ECU Poll of the U.S. Senate election in Georgia shows Democrat Raphael Warnock tied with Republican challenger Herschel Walker, 49% to 49%, among likely voters (and those who already voted), with 2% supporting Libertarian Chase Oliver. In the race for Governor of Geor...

Chicago, IL. November 7, 2022- Content Carnivores, a digital marketing agency, is honored to be a Silver Sponsor at BioFuture, being held in-person in New York on November 7-9 and virtually November 14-16. This is second annual event presented by Demy-Colton, the team that co-...

TORONTO - Alberta Distillers Ltd., makers of the No. 1 selling 100% rye whisky in the world¹, Alberta® Premium, is proud to announce the return of its highly coveted Alberta Premium Cask Strength Rye. The 2022 release of the award-winning* 100% Canadian rye whisky marks the fo...

The latest ECU Poll of the U.S. Senate election in North Carolina, conducted November 1-3, shows Republican Ted Budd leading Democrat Cheri Beasley, 52% to 46%, among likely voters, with just 1% of the poll respondents reporting they are undecided (and the remaining 1% express...

BOSTON – Advisors Living, the residential sales platform of Boston Realty Advisors, the largest Boston-based independent commercial real estate and consulting firm, has opened a new sales office in Merrimac, MA, an office ideally located to serve Greater Newburyport and the Me...

The countdown to the 12th Route du Rhum is upon us, on Sunday, November 6th at 1:02 pm the race will start in Saint Malo to reach Guadeloupe. Bollé will outfit six skippers in four different categories: Ultim, Ocean Fifty, Imoca and Class 40 in this quest for the queen of solo...

Edmonton, Alberta, Canada, November 3, 2022- Pacylex today announced that data from the ongoing Phase 1 dose escalation clinical trial of PCLX-001, an N-myristoyltransferase (NMT) inhibitor, as well as the scientific rationale for its use in acute myeloid leukemia (AML) patien...

Edmonton, Alberta, Canada, November 2, 2022 Pacylex, a clinical-stage NMT inhibitor company developing first-in-class therapies for leukemia, lymphoma, and solid tumor cancers, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New...

DALLAS, TX -- November 2nd, 2022 -- U.S. Global Investors, Inc. (NASDAQ: GROW): Stonegate Capital Partners initiates their coverage on U.S. Global Investors, Inc. The full report can be accessed by clicking on the following link: https://stonegateinc.com/reports/GROW_Q3FY22.pd...